Ocular gene transfer of active TGF-β induces changes in anterior segment morphology and elevated IOP in rats

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 1, 2010, Pages 308-318

  Robertson, Jennifer V ^a   Golesic, Elizabeth ^a   Gauldie, Jack ^a,b   West Mays, Judith A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA; ACTIN; CADHERIN; COLLAGEN TYPE 4; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EYE SYNECHIA; GENE OVEREXPRESSION; HISTOPATHOLOGY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; OCULAR FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRABECULAR MESHWORK; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; CATARACT; CONGENITAL MALFORMATION; DISEASE MODEL; FIBROSIS; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IRIDOCORNEAL ENDOTHELIAL SYNDROME; MALE; METABOLISM; NICK END LABELING; OCULOPLETHYSMOGRAPHY; PATHOLOGY; PHYSIOLOGY; RETINA DISEASE; WISTAR RAT;

ACTINS; ADENOVIRIDAE; ANIMALS; ANTERIOR EYE SEGMENT; CADHERINS; CATARACT; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IN SITU NICK-END LABELING; INTRAOCULAR PRESSURE; IRIDOCORNEAL ENDOTHELIAL SYNDROME; MALE; MICROSCOPY, FLUORESCENCE; OCULAR HYPERTENSION; RATS; RATS, WISTAR; RETINAL DISEASES; TONOMETRY, OCULAR; TRABECULAR MESHWORK; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75749152097     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3380     Document Type: Article

References (124)

1. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577-584.
2. Schuppan D, Koda M, Bauer M, Hahn EG. Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets? Acta Gastroenterol Belg. 2000;63:366-370.
3. Margetts PJ, Bonniaud P, Liu L, et al. Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005;16:425-436.
4. Robertson JV, Nathu Z, Najjar A, Dwivedi D, Gauldie J, West-Mays JA. Adenoviral gene transfer of bioactive TGF-beta1 to the rodent eye as a novel model for anterior subcapsular cataract. Mol Vis. 2007;13:457-469.
5. Piao S, Ryu JK, Shin HY, et al. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. Int J Androl. 2008;31:346-353.
6. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 2007;35:661-664.
7. Vallance BA, Gunawan MI, Hewlett B, et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol. 2005;289:G116-G128.
8. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovectormediated gene transfer of active transforming growth factorbeta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100:768-776.
9. Flugel-Koch C, Ohlmann A, Piatigorsky J, Tamm ER. Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice. Dev Dyn. 2002;225:111-125.
10. Srinivasan Y, Lovicu FJ, Overbeek PA. Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest. 1998;101:625-634.
11. Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGF-beta2 for the pathogenesis of the disease. Exp Eye Res. 2005;81:1-4.
12. Weinreb RN. Intraocular pressure: reports and consensus statements of the 4th Global AIGS. Consensus Meeting on Intraocular Pressure. Amsterdam: Kugler Publications; 2007.
13. Shields MB. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1997.
14. Allingham RR, Shields MB. Shields' Textbook of Glaucoma. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
15. Kessing SV, Thygesen J. Primary Angle-Closure and Angle-Closure Glaucoma. The Hague: Kugler; 2007.
16. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59:723-727.
17. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefe's Arch Clin Exp Ophthalmol. 2001;239:109-113.
18. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefe's Arch Clin Exp Ophthalmol. 2001;239:199-207.
19. Ozcan AA, Ozdemir N, Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int Ophthalmol. 2004;25:19-22.
20. Yu XB, Sun XH, Dahan E, et al. Increased levels of transforming growth factor-beta1 and-beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surgery Lasers Imaging. 2007;38:6-14.
21. Gottanka J, Chan D, Eichhorn M, Lutjen-Drecoll E, Ethier CR. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
22. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGF-beta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47:226-234.
23. Bachmann B, Birke M, Kook D, Eichhorn M, Lutjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47:2011-2020.
24. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E, Birke M. Biochemical and morphological analysis of basement membrane component expression in corneoscleral and cribriform human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:794-801.
25. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res. 2003;77:757-765.
26. Samuel SK, Hurta RA, Kondaiah P, et al. Autocrine induction of tumor protease production and invasion by a metallothioneinregulated TGF-beta 1 (Ser223, 225). EMBO J. 1992;11:1599-1605.
27. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor: expression and characterization of mutant proteins. J Biol Chem. 1989;264:13660-13664.
28. Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther. 1999;10:2667-2672.
29. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol. 2003;163:2575-2584.
30. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol. 2001;12:2029-2039.
31. Kolb M, Bonniaud P, Galt T, et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Resp Cell Mol Biol. 2002;27:141-150.
32. Addison CL, Hitt M, Kunsken D, Graham FL. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J Gen Virol. 1997;78(pt 7):1653-1661.
33. Celis JE. Cell Biology: A Laboratory Handbook. 3rd ed. Boston: Elsevier/Academic; 2006.
34. Moore CG, Milne ST, Morrison JC. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest Ophthalmol Vis Sci. 1993;34:363-369.
35. Reitsamer HA, Kiel JW, Harrison JM, Ransom NL, McKinnon SJ. TonoPen measurement of intraocular pressure in mice. Exp Eye Res. 2004;78:799-804.
36. Ohashi M, Aihara M, Saeki T, Araie M. Efficacy of TonoLab in detecting physiological and pharmacological changes in rat intraocular pressure: comparison of TonoPen and microneedle manometry. Jpn J Ophthalmol. 2008;52:399-403.
37. Grozdanic S, Sakaguchi DS, Kwon YH, Kardon RH, Sonea IM. Characterization of the pupil light reflex, electroretinogram and tonometric parameters in healthy rat eyes. Curr Eye Res. 2002;25:69-78.
38. Jia L, Cepurna WO, Johnson EC, Morrison JC. Effect of general anesthetics on IOP in rats with experimental aqueous outflow obstruction. Invest Ophthalmol Vis Sci. 2000;41:3415-3419.
39. Lai CM, Brankov M, Zaknich T, et al. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum Gene Ther. 2001;12:1299-1310.
40. Yu H, Wu J, Li H, et al. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression. Biochem Biophys Res Commun. 2007;361:946-952.
41. Ahmed FA, Hegazy K, Chaudhary P, Sharma SC. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res. 2001;913:133-139.
42. Thanos S, Naskar R. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp Eye Res. 2004;79:119-129.
43. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther. 2003;10:977-982.
44. Zhu YT, Hayashida Y, Kheirkhah A, He H, Chen SY, Tseng SC. Characterization and comparison of intercellular adherent junctions expressed by human corneal endothelial cells in vivo and in vitro. Invest Ophthalmol Vis Sci. 2008;49:3879-3886.
45. Nakano Y, Oyamada M, Dai P, Nakagami T, Kinoshita S, Takamatsu T. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest Ophthalmol Vis Sci. 2008;49:93-104.
46. Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K. Snail is required for TGF-β-induced endothelialmesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci. 2008;121:3317-3324.
47. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1-L8.
48. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952-961.
49. Nagaraju M, Saleh M, Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci. 2007;48:4573-4579.
50. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci. 2005;46:175-182.
51. Saika S, Ikeda K, Yamanaka O, et al. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest. 2005;85:474-486.
52. Saika S, Yamanaka O, Ikeda K, et al. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest. 2005;85:838-850.
53. Saika S, Ikeda K, Yamanaka O, et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol. 2006;290:C282-C289.
54. Saika S, Yamanaka O, Nishikawa-Ishida I, et al. Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model. Arch Ophthalmol. 2007;125:647-654.
55. Lu J, Lu Z, Reinach P, et al. TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. Exp Cell Res. 2006;312:3631-3640.
56. Petroll WM, Jester JV, Barry-Lane PA, Cavanagh HD. Effects of basic FGF and TGF-beta 1 on F-actin and ZO-1 organization during cat endothelial wound healing. Cornea. 1996;15:525-532.
57. Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S. Inhibitory effect of blocking TGF-beta/Smad signal on injuryinduced fibrosis of corneal endothelium. Mol Vis. 2008;14:2272-2281.
58. Yamagami S, Yokoo S, Mimura T, Amano S. Effects of TGF-beta2 on immune response-related gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci. 2004;45:515-521.
59. Borisuth NS, Tripathi BJ, Tripathi RC. Identification and partial characterization of TGF-beta 1 receptors on trabecular cells. Invest Ophthalmol Vis Sci. 1992;33:596-603.
60. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1995;36:2211-2215.
61. Li J, Tripathi BJ, Chalam KV, Tripathi RC. Transforming growth factor-beta 1 and-beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells. Invest Ophthalmol Vis Sci. 1996;37:2778-2782.
62. Tamm ER, Siegner A, Baur A, Lutjen-Drecoll E. Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res. 1996;62:389-397.
63. Wordinger RJ, Fleenor DL, Hellberg PE, et al. Effects of TGFbeta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48:1191-1200.
64. Zhao X, Ramsey KE, Stephan DA, Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci. 2004;45:4023-4034.
65. Lindsey JD, Weinreb RN. Elevated intraocular pressure and transgenic applications in the mouse. J Glaucoma. 2005;14:318-320.
66. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508-518.
67. Smith RS, Korb D, John SW. A goniolens for clinical monitoring of the mouse iridocorneal angle and optic nerve. Mol Vis. 2002;8:26-31.
68. Grozdanic SD, Betts DM, Sakaguchi DS, Allbaugh RA, Kwon YH, Kardon RH. Laser-induced mouse model of chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2003;44:4337-4346.
69. Chang B, Smith RS, Hawes NL, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21:405-409.
70. Anderson MG, Smith RS, Savinova OV, et al. Genetic modification of glaucoma-associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet. 2001;2:1.
71. Libby RT, Smith RS, Savinova OV, et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science. 2003;299:1578-1581.
72. Weng J, Luo J, Cheng X, et al. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proc Natl Acad Sci U S A. 2008;105:6081-6086.
73. Reneker LW, Silversides DW, Xu L, Overbeek PA. Formation of corneal endothelium is essential for anterior segment development: a transgenic mouse model of anterior segment dysgenesis. Development. 2000;127:533-542.
74. Casson RJ. Anterior chamber depth and primary angle-closure glaucoma: an evolutionary perspective. Clin Exp Ophthalmol. 2008;36:70-77.
75. Casson RJ, Newland HS, Muecke J, et al. Gonioscopy findings and prevalence of occludable angles in a Burmese population: the Meiktila Eye Study. Br J Ophthalmol. 2007;91:856-859.
76. Casson RJ, Newland HS, Muecke J, et al. Prevalence of glaucoma in rural Myanmar: the Meiktila Eye Study. Br J Ophthalmol. 2007;91:710-714.
77. Yip JL, Foster PJ. Ethnic differences in primary angle-closure glaucoma. Curr Opin Ophthalmol. 2006;17:175-180.
78. He M, Foster PJ, Johnson GJ, Khaw PT. Angle-closure glaucoma in East Asian and European people: different diseases? Eye. 2006;20:3-12.
79. See JL, Chew PT. Glaucoma in Singapore. J Glaucoma. 2004;13:417-420.
80. Wang N, Wu H, Fan Z. Primary angle closure glaucoma in Chinese and Western populations. Chin Med J (Engl). 2002;115:1706-1715.
81. Chew PT, Aung T. Primary angle-closure glaucoma in Asia. J Glaucoma. 2001;10:S7-S8.
82. Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001;85:1277-1282.
83. Cooper R. Acute primary closed-angle glaucoma in Chinese people. Aust N Z J Ophthalmol. 1999;27:360.
84. Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31:127-141.
85. Panday VA, Rhee DJ. Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update. 2007;8:271-276.
86. Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18:129-133.
87. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67:75-93.
88. Bhattacharyya KB, Basu S. Acute myopia induced by topiramate: report of a case and review of the literature. Neurol India. 2005;53:108-109.
89. Ezra DG, Storoni M, Whitefield LA. Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment. Eye. 2006;20:128-129.
90. Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Saf. 2003;26:749-767.
91. Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003;110:2040-2044.
92. Sigler-Villanueva A, Tahvanainen E, Lindh S, Dieguez-Lucena J, Forsius H. Autosomal dominant cornea plana: clinical findings in a Cuban family and a review of the literature. Ophthalmic Genet. 1997;18:55-62.
93. Ray K, Mukhopadhyay A, Acharya M. Recent advances in molecular genetics of glaucoma. Mol Cell Biochem. 2003;253:223-231.
94. Mandal AK, Netland PA. Glaucoma in aphakia and pseudophakia after congenital cataract surgery. Ind J Ophthalmol. 2004;52:185-198.
95. Gedde SJ. Management of glaucoma after retinal detachment surgery. Curr Opin Ophthalmol. 2002;13:103-109.
96. Yoneda K, Nakano M, Mori K, Kinoshita S, Tashiro K. Diseaserelated quantitation of TGF-beta3 in human aqueous humor. Growth Factors. 2007;25:160-167.
97. Choi JS, Kim YY. Progression of peripheral anterior synechiae after laser iridotomy. Am J Ophthalmol. 2005;140:1125-1127.
98. Lai JS, Tham CC, Chua JK, Poon AS, Lam DS. Laser peripheral iridoplasty as initial treatment of acute attack of primary angleclosure: a long-term follow-up study. J Glaucoma. 2002;11:484-487.
99. Cook CD, Evans JR, Johnson GJ. Is anterior chamber lens implantation after intracapsular cataract extraction safe in rural black patients in Africa? A pilot study in KwaZulu-Natal, South Africa. Eye. 1998;12(pt 5):821-825.
100. Ozdal MP, Mansour M, Deschenes J. Ultrasound biomicroscopic evaluation of the traumatized eyes. Eye. 2003;17:467-472.
101. Moriarty AP, McHugh JD, Spalton DJ, Ffytche TJ, Shah SM, Marshall J. Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flare meter. Ophthalmology. 1993;100:1263-1267.
102. Matsuo T, Taira Y, Nagayama M, Baba T. Angle-closure glaucoma as a presumed presenting sign in patients with syphilis. Jpn J Ophthalmol. 2000;44:305-308.
103. Petroll WM, Jester JV, Bean JJ, Cavanagh HD. Myofibroblast transformation of cat corneal endothelium by transforming growth factor-beta1,-beta2, and-beta3. Invest Ophthalmol Vis Sci. 1998;39:2018-2032.
104. Usui T, Takase M, Kaji Y, et al. Extracellular matrix production regulation by TGF-beta in corneal endothelial cells. Invest Ophthalmol Vis Sci. 1998;39:1981-1989.
105. Nawshad A, Lagamba D, Polad A, Hay ED. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 2005;179:11-23.
106. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol. 2004;85:47-64.
107. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24:5764-5774.
108. Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGF-betamediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 2006;17:19-27.
109. Eagle RC Jr, Font RL, Yanoff M, Fine BS. Proliferative endotheliopathy with iris abnormalities: the iridocorneal endothelial syndrome. Arch Ophthalmol. 1979;97:2104-2111.
110. Shields MB. Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc. 1983;81:736-784.
111. Laganowski HC, Sherrard ES, Muir MG, Buckley RJ. Distinguishing features of the iridocorneal endothelial syndrome and posterior polymorphous dystrophy: value of endothelial specular microscopy. Br J Ophthalmol. 1991;75:212-216.
112. Kupfer C, Chan CC, Burnier M Jr, Kaiser-Kupfer MI. Histopathology of the ICE syndrome. Trans Am Ophthalmol Soc. 1992;90:149-156, discussion 156-160.
113. Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992;110:346-350.
114. Morris RW, Dunbar MT. Atypical presentation and review of the ICE syndrome. Optometry. 2004;75:13-25.
115. Hassel B, Samuelson DA, Lewis PA, Gelatt KN. Immunocytochemical localization of smooth muscle actin-containing cells in the trabecular meshwork of glaucomatous and nonglaucomatous dogs. Vet Ophthalmol. 2007;10(suppl 1):38-45.
116. Ryland TR, Lewis PA, Chisholm M, Gelatt KN, Samuelson DA. Localization of smooth muscle actin in the iridocorneal angle of normal and spontaneous glaucomatous beagle dogs. Vet Ophthalmol. 2003;6:205-209.
117. Grainger DJ, Mosedale DE, Metcalfe JC. TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev. 2000;11:133-145.
118. Cordeiro MF, Bhattacharya SS, Schultz GS, Khaw PT. TGF-beta1,-beta2, and-beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000;41:756-763.
119. Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-beta(1) signaling pathway. Int J Cardiol. In press.
120. Zhang D, Jacobberger JW. TGF-beta 1 perturbation of the fibroblast cell cycle during exponential growth: switching between negative and positive regulation. Cell Prolif. 1996;29:289-307.
121. Minchiotti S, Stampachiacchiere B, Micera A, et al. Human idiopathic epiretinal membranes express NGF and NGF receptors. Retina. 2008;28:628-637.
122. Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefe's Arch Clin Exp Ophthalmol. 1997;235:780-785.
123. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther. 1994;1:122-126.
124. Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest. 2004;84:1259-1270.